Collectively, these factors exacerbate AD pathology, emphasizing TREM2’s central role in both AD susceptibility and progression, and reinforcing its potential as a therapeutic target to enhance microglial protective function and combat disease mechanisms [13]. Here, TREM2 is linked to Alzheimer disease.